The inauguration of a new lab brings the Life Sciences Innovation Building to near capacity fulfilling a vision to create the Capital Region Biotech Hub.
Governor Hochul announced last Thursday that France-based One Biosciences has chosen Albany as its first U.S. location. It will be located in LSIB at 150 New Scotland Avenue, which also houses CBET and other biotech businesses.
“Life science research and development is vital to creating the treatments that help people heal, survive and live longer,” Governor Hochul said. “Through our targeted efforts, we are working to ensure that cutting edge companies like One Biosciences not only grow here, but that the next generation of medical breakthroughs happen in New York State.”
One Biosciences will bring its proprietary technology to this first-of-its-kind hub in Albany to address the unmet clinical and scientific needs to characterize the tumor ecosystem. The company is developing technology to better understand each patient’s cancer, helping doctors around the world to match patients to the therapies most likely to help them.
“This initiative would not have been achievable without support from partners such as RPI, UAlbany, and HVCC,” said CBET Executive Director, Michelle Lewis. “It plays a key role in attracting businesses like One Biosciences.”
The event featured poster presentations, keynote discussions and a reception welcoming our new neighbors.
Stories about the new partner were covered in the Times Union, Albany Business Journal, MSN and on WTEN- Channel 10. (May require subscriptions to view)
View our photo gallery from the event.
Social